February 25, 1997





          Securities & Exchange Commission
          Judiciary Plaza
          450 Fifth Street, N.W.
          Washington, D.C.  20549

               Re:  Gerber Scientific, Inc.
                    Commission File No. 1-5865

          Gentlemen:

          Pursuant  to   regulations  of   the   Securities  and   Exchange
          Commission,  submitted herewith  for filing  on behalf  of Gerber
          Scientific, Inc. (the "Company") is  the Company's Form 10-Q  for
          the quarter ended January 31, 1997.

          This  filing is  being  effected by  direct  transmission to  the
          Commission's EDGAR System.

                                        Very truly yours,




                                        /s/ Gary K. Bennett
                                        Senior Vice President, Finance<PAGE>

<PAGE>1
                    UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                                 WASHINGTON, D.C.  20549


                                        FORM 10-Q

               (MARK ONE) QUARTERLY REPORT /X/  OR TRANSITION REPORT /  /
                           PURSUANT TO SECTION 13 OR 15(d) OF
                           THE SECURITIES EXCHANGE ACT OF 1934


        For the quarter ended
          January 31, 1997                            Commission File No. 1-5865



                                GERBER SCIENTIFIC, INC.               
                ------------------------------------------------------
                 (Exact name of Registrant as specified in its charter)




                  CONNECTICUT                                   06-0640743     
        -------------------------------                      -------------------

        (State or other jurisdiction of                       (I.R.S. Employer
        incorporation or organization)                      Identification No.)



          83 Gerber Road West, South Windsor, Connecticut             06074 
        --------------------------------------------------         ----------
              (Address of principal executive offices)             (Zip Code)



        Registrant's Telephone Number, including area code       (203) 644-1551 
                                                                ----------------


        Indicate by check mark whether the Registrant (1) has  filed all reports
        required to be filed by  Section 13 or 15(d) of the  Securities Exchange
        Act  of 1934 during the preceding 12  months (or for such shorter period
        that the Registrant was required to  file such reports) and (2) has been
        subject to such filing requirements for the past 90 days.


                                   Yes /X/.   No /  /.

        At January 31, 1997, 23,294,150 shares of common stock of the Registrant
        were outstanding.
<PAGE>2

                                 GERBER SCIENTIFIC, INC.
                                    AND SUBSIDIARIES

                        CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                             Quarter Ended January 31, 1997


                                                                              
                                                                       PAGE


        Part I - Financial Information

           Item 1.  Consolidated Financial Statements:

                    Statement of Earnings for the three months
                    ended January 31, 1997 and 1996                       1

                    Statement of Earnings for the nine months                  
                    ended January 31, 1997 and 1996                       2

                    Balance Sheet at January 31, 1997 and
                    April 30, 1996                                        3

                    Statement of Cash Flows for the nine months
                    ended January 31, 1997 and 1996                       4

                    Notes to Financial Statements                         5

                    Independent Accountants' Report                       8

           Item 2.  Management's Discussion and Analysis of 
                    Financial Condition and Results of Operations         9


        Part II - Other Information

           Item 1.  Legal Proceedings                                    12

           Item 5.  Other Information

           Item 6.  Exhibits and Reports on Form 8-K


        Signature                                                        13


        Exhibit Index
<PAGE>3

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                           CONSOLIDATED STATEMENT OF EARNINGS
       ------------------------------------------------------------------------
                                                           In Thousands 
                                                    (except per share amounts)  
       ------------------------------------------------------------------------
       Three Months Ended January 31,                    1997            1996
       ------------------------------------------------------------------------

       Revenue:

          Product sales                               $  83,041       $  75,522
          Service                                        11,550          11,362
                                                      ---------       ---------
                                                         94,591          86,884
                                                      ---------       ---------
       Costs and Expenses:

          Cost of product sales                          44,825          40,707
          Cost of service                                 7,457           7,281
          Selling, general and administrative            29,335          26,374
          Research and development expenses               7,659           6,790
                                                      ---------       ---------
                                                         89,276          81,152
                                                      ---------       ---------

       Operating income                                   5,315           5,732

       Other income                                         717           1,558
       Interest expense                                     (88)           (139)
                                                      ---------       ---------
       Earnings before income taxes                       5,944           7,151

       Provision for income taxes                         1,800           2,000
                                                      ---------       ---------

       Net earnings                                   $   4,144       $   5,151
                                                      =========       =========

       Net earnings per common share                  $     .18       $     .22
                                                      =========       =========

       Dividends paid per common share                $     .08       $     .08
                                                      =========       =========
       Average common shares outstanding                 23,357          23,516
                                                      =========       =========


                                 See Accompanying Notes

                                            1

<PAGE>4

                        GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                           CONSOLIDATED STATEMENT OF EARNINGS
       ------------------------------------------------------------------------
                                                           In Thousands 
                                                    (except per share amounts)  
       ------------------------------------------------------------------------
       Nine Months Ended January 31,                     1997            1996
       ------------------------------------------------------------------------
       Revenue:

          Product sales                               $ 240,919       $ 231,294
          Service                                        34,431          33,939
                                                      ---------       ---------
                                                        275,350         265,233
                                                      ---------       ---------
       Costs and Expenses:

          Cost of product sales                         132,027         124,229
          Cost of service                                21,819          22,240
          Selling, general and administrative            88,310          82,100
          Research and development expenses              21,868          18,922
                                                      ---------       ---------
                                                        264,024         247,491
                                                      ---------       ---------

       Operating income                                  11,326          17,742

       Other income                                       4,017           3,871 
       Interest expense                                    (261)           (336)
                                                      ---------       ---------

       Earnings before income taxes                      15,082          21,277

       Provision for income taxes                         4,200           6,100
                                                      ---------       ---------
       Net earnings                                   $  10,882       $  15,177
                                                      =========       =========

       Net earnings per common share                  $     .47       $     .64
                                                      =========       =========

       Dividends paid per common share                $     .24       $     .24
                                                      =========       =========
       Average common shares outstanding                 23,352          23,808
                                                      =========       =========


                                 See Accompanying Notes


                                            2
<PAGE>5

                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                                CONSOLIDATED BALANCE SHEET
     -------------------------------------------------------------------------  
                                                             In Thousands
     -------------------------------------------------------------------------  
                                                       January 31,    April 30,
                                                          1997          1996   
     -------------------------------------------------------------------------  
                                          ASSETS

       Current Assets:
         Cash and short-term cash investments          $    8,528    $    8,704
         Accounts receivable                               83,766        74,035
         Inventories                                       59,418        63,196
         Prepaid expenses                                  14,318        12,021
                                                       ----------    ----------
                                                          166,030       157,956
                                                       ----------    ----------
       Investments and long-term 
         receivables                                       47,393        59,594
                                                       ----------    ----------

       Property, plant and equipment                      116,999       109,430
         Less accumulated depreciation                     56,651        54,692
                                                       ----------    ----------
                                                           60,348        54,738
                                                       ----------    ----------

       Intangible assets                                   49,254        48,576
         Less accumulated amortization                     10,460         9,327
                                                       ----------    ----------
                                                           38,794        39,249
                                                       ----------    ----------
       Other assets                                         2,070         1,451
                                                       ----------    ----------
                                                       $  314,635    $  312,988
                                                       ==========    ==========

                           LIABILITIES AND SHAREHOLDERS' EQUITY
       Current Liabilities:
         Notes payable                                 $       --    $       --
         Current maturities of long-term debt                 193           193
         Accounts payable                                  11,522        12,895
         Accrued compensation and benefits                 11,314        13,673
         Other accrued liabilities                         18,795        18,351
         Deferred revenue and litigation award              5,818         8,512
         Advances on sales contracts                        3,104         2,672
                                                       ----------    ----------
                                                           50,746        56,296
                                                       ----------    ----------
       Noncurrent Liabilities:
         Deferred income taxes                             11,440        10,056
         Long-term debt                                     7,194         7,338
                                                       ----------    ----------
                                                           18,634        17,394
                                                       ----------    ----------

       Contingencies and Commitments 

       Shareholders' Equity:
         Preferred stock, no par value; authorized
           10,000,000 shares; no shares issued                 --            --
         Common stock, $1.00 par value; authorized
           65,000,000 shares; issued and outstanding 
           23,294,150 and 23,198,725 shares                23,294        23,199
         Paid-in capital                                   35,863        35,218
         Retained earnings                                184,616       179,307
         Cumulative translation component                   1,482         1,574
                                                       ----------    ----------
                                                          245,255       239,298
                                                       ----------    ----------
                                                       $  314,635    $  312,988
                                                       ==========    ==========

                                  See Accompanying Notes

                                            3
<PAGE>6

                         GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                           CONSOLIDATED STATEMENT OF CASH FLOWS
       -----------------------------------------------------------------------
                                                               In Thousands
       Nine Months Ended January 31,                        1997        1996
       -----------------------------------------------------------------------
       CASH PROVIDED BY (USED FOR):
                                                                     
       Operating Activities
         Net earnings                                    $  10,882   $  15,177
         Adjustments to reconcile net earnings to
           cash provided by operating activities:
             Depreciation and amortization                   8,876       7,979
             Deferred income taxes                           1,384         530
             Changes in operating accounts, net of        
               effects from business acquisitions:
                 Receivables                                (9,914)     (2,732)
                 Inventories                                   410      (7,364)
                 Prepaid expenses                           (2,297)        346
                 Accounts payable and accrued expenses      (5,550)    (11,811) 
                                                         ---------   ---------
       Provided by Operating Activities                      3,791       2,125
                                                         ---------   ---------
       Financing Activities
         Purchase of common stock                               --     (11,334)
         Repayments of long-term debt                         (144)       (144)
         Exercise of stock options                             740         723
         Dividends on common stock                          (5,573)     (5,685)
                                                         ---------   ---------
       (Used for) Financing Activities                      (4,977)    (16,440)
                                                         ---------   ---------
       Investing Activities
         Long-term debt securities                          11,751      22,781
         Business acquisitions                                  --        (486)
         Additions to property, plant and equipment         (9,861)    (10,099)
         Intangible and other assets                        (1,421)     (1,758)
         Other long-term investments                           541      (1,334)
                                                         ---------   ---------
       Provided by Investing Activities                      1,010       9,104
                                                         ---------   ---------

       (Decrease) in Cash and
         Short-Term Cash Investments                          (176)     (5,211)

       Cash and Short-Term Cash Investments,
         Beginning of Period                                 8,704      10,208
                                                         ---------   ---------
       Cash and Short-Term Cash Investments, 
         End of Period                                   $   8,528   $   4,997
                                                         =========   =========


                                  See Accompanying Notes


                                            4
<PAGE>7

                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                      NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

        Note 1

        The consolidated balance sheet at  January 31, 1997, the  consolidated
        statements  of earnings  for the three-  and nine-month  periods ended
        January  31, 1997  and 1996,  and the  consolidated statement  of cash
        flows for the nine-month  periods ended January 31, 1997 and  1996 are
        unaudited but, in the opinion of the Company, include all adjustments,
        consisting only  of normal recurring  accruals, necessary  for a  fair
        statement  of the results  for the  interim periods.   The  results of
        operations  for the nine-month period  ended January 31,  1997 are not
        necessarily  indicative of  the results  to be  expected for  the full
        fiscal year.

        Note 2

        The classification of inventories was as follows (in thousands):

                                     January 31, 1997      April 30, 1996
                                     ----------------      --------------
              Raw materials and
                purchased parts          $  49,913            $  51,493
          
              Work in process                9,505               11,703
                                         ---------            ---------
                                         $  59,418            $  63,196
                                         =========            =========

        Note 3

        Net earnings  per common  share were  calculated on  the basis  of the
        weighted average number  of shares  of common stock  and common  stock
        equivalents outstanding during each period.

        Note 4

        Included  in the  nine months  ended January  31, 1997  was a  gain of
        $1,032,000 ($.04 per share) resulting from life insurance benefits the
        Company received upon the death of Mr. H. Joseph Gerber, the Company's
        former Chairman and President. 

        Note 5

        In December, 1996 the Court of Appeals for the United  Kingdom reduced
        the award to the Company from  Lectra Systemes, S.A. of France and its
        U.K. subsidiary (Lectra) in  a patent infringement suit.   The earlier
        award to the Company by the  High Court of Justice, Chancery Division,
        had been for approximately $5.9 million, which was paid to the Company
        but was  not recognized as  income pending the outcome  of the appeals
        process.   As a result of  the Court of Appeals  decision, the Company
        was required to pay  back to Lectra approximately $3.1  million, which
        included  interest.   The Company  is pursuing  further appeal  of the
        issues  in  this litigation  and has  deferred any  income recognition
        until such time as the uncertainty is resolved.


                                          5
<PAGE>8

                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                      NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                           

        Note 6

        Subsequent to the end of the third quarter, the Company's wholly-owned
        subsidiary,  Gerber Garment  Technology,  Inc.  (GGT),  completed  the
        acquisition of Cutting  Edge, Inc., of Marblehead, Massachusetts.   On
        February 12, 1997, GGT  acquired all the outstanding stock  of Cutting
        Edge in exchange  for cash of $7.5 million.  Cutting Edge is a leading
        supplier of high-performance, single-layer  fabric cutting systems and
        in its  most recent year ended  December 31, 1996 had  annual sales of
        approximately $16 million.<PAGE>



                                          6
<PAGE>9


                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES



        With  respect to  the unaudited  consolidated financial  statements of
        Gerber Scientific, Inc. and  subsidiaries at January 31, 1997  and for
        the three-  and nine-month  periods ended  January 31, 1997  and 1996,
        KPMG  Peat Marwick LLP has made a  review (based on procedures adopted
        by  the American Institute of Certified Public Accountants) and not an
        audit, as set forth  in their separate report dated  February 19, 1997
        appearing  on page 8.  That report does  not express an opinion on the
        interim  unaudited  consolidated  financial  information.    KPMG Peat
        Marwick  LLP has not carried  out any significant  or additional audit
        tests beyond those which would have been necessary if their report had
        not been included.   Accordingly,  such report  is not  a "report"  or
        "part  of the Registration Statement" within the meaning of Sections 7
        and  11 of the Securities Act of  1933 and the liability provisions of
        Section 11 of such Act do not apply.




                                          7

<PAGE>10

                             INDEPENDENT ACCOUNTANTS' REPORT


            To the Board of Directors and Shareholders of
            Gerber Scientific, Inc.


            We  have made a review of the consolidated statement of earnings
            of Gerber Scientific, Inc.  and subsidiaries for the three-month
            and  nine-month periods  ended January  31, 1997  and 1996,  the
            consolidated statement of cash  flows for the nine-month periods
            ended January  31, 1997 and  1996, and the  consolidated balance
            sheet  as  of January  31,  1997  in  accordance with  standards
            established  by  the  American  Institute  of  Certified  Public
            Accountants.   We  have previously  audited, in  accordance with
            generally   accepted  auditing  standards,   and  expressed  our
            unqualified  opinion  dated May  23,  1996  on the  consolidated
            financial statements  for the  year ended  April  30, 1996  (not
            presented herein).  The aforementioned financial  statements are
            the responsibility of the Company's management.

            A review  of interim financial information  consists principally
            of applying  analytical review procedures to  financial data and
            making  inquiries  of  persons  responsible  for  financial  and
            accounting matters.  It  is substantially less in scope  than an
            examination  in  accordance  with  generally  accepted  auditing
            standards,  the  objective  of which  is  the  expression  of an
            opinion  regarding the  financial statements  taken as  a whole.
            Accordingly, we do not express such an opinion.

            Based   on  our  review,  we  are  not  aware  of  any  material
            modifications   that  should   be  made   to   the  accompanying
            consolidated statement of earnings for the three-month and nine-
            month periods ended January 31, 1997 and  1996, the consolidated
            statement of cash flows for the nine-month periods ended January
            31,  1997  and 1996,  or the  consolidated  balance sheet  as of
            January 31, 1997  for them  to be in  conformity with  generally
            accepted  accounting  principles.    Also, in  our  opinion  the
            information in the accompanying consolidated balance sheet as of
            April 30, 1996 is fairly presented, in all material respects, in
            relation to  the consolidated  balance sheet  from which it  has
            been derived.




                                       /s/ KPMG PEAT MARWICK LLP  


            Hartford, Connecticut
            February 19, 1997



                                            8
<PAGE>11

                       GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                        MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                     FINANCIAL CONDITION AND RESULTS OF OPERATIONS


          FINANCIAL CONDITION

          The Company's  ratio of current assets to  current liabilities was
          3.3 to  1 at January 31, 1997, compared with 2.8 to 1 at April 30,
          1996.    Net working  capital  increased  $13.6 million  from  the
          beginning  of  the  current  fiscal  year  to  $115.3  million  at
          January 31, 1997.

          The  Company's  cash  and  short-term  investments  totalled  $8.5
          million  at January  31, 1997,  substantially the  same as  of the
          beginning of  the  fiscal year,  and  adequate for  the  Company's
          normal operating requirements.  The  Company's liquidity continued
          to be  supplemented by a portfolio of longer-term debt securities,
          primarily tax-exempt municipal bonds, which totalled $47.1 million
          at January 31, 1997.  This longer-term portfolio has declined from
          $58.9 million as  of the beginning of the  current fiscal year for
          the reasons discussed below.    

          Operating activities  provided $3.8 million  in cash in  the first
          nine  months  of  the current  fiscal  year.    Cash generated  by
          earnings  and   the   non-cash  charges   for   depreciation   and
          amortization   was  partially   offset  by   growth  in   accounts
          receivable.  The growth  in receivables was related to  the higher
          volume  of  business  and partly  to  extended  payment terms  for
          certain   sales  of  computer-to-plate  imaging  systems  for  the
          printing industry.

          During  the  quarter  ended  January 31,  1997,  the  Company  was
          required to return approximately  $3.1 million to Lectra Systemes,
          S.A. (Lectra) as a result of a Court of Appeals decision in a U.K.
          patent  infringement suit.   In  fiscal year  1995, a  lower court
          awarded the Company a $5.9 million judgment against Lectra in this
          litigation.  Income  recognition of the  amounts involved in  this
          litigation  has  been  deferred   until  the  appeals  process  is
          resolved.  The  $3.1 million  payment to Lectra  reduced the  cash
          provided by operations for the nine months ended January 31, 1997.

          The  principal non-operating uses of cash in the nine months ended
          January 31, 1997 were additions to property, plant, and  equipment
          of $9.9 million and  the payment of dividends  on common stock  of
          $5.6 million.   The Company anticipates  that capital expenditures
          for the  current fiscal year  will be in  the range of $12  to $13
          million and expects to fund these additions with cash on  hand and
          cash from operations.

          Subsequent   to  January  31,  1997,  the  Company's  wholly-owned
          subsidiary, Gerber Garment  Technology, Inc. (GGT), completed  the
          acquisition of Cutting Edge,  Inc., of Marblehead,  Massachusetts.
          On  February 12, 1997, GGT  acquired all the  outstanding stock of
          Cutting Edge in exchange for  cash of $7.5 million.   Cutting Edge
          is  a leading  supplier of  high-performance, single-layer  fabric
          cutting systems and  in its  most recent year  ended December  31,
          1996 had annual sales of approximately $16 million.

                                           9
<PAGE>12

          The  Company's total  debt at  January 31,  1997 was  $7.4 million
          compared  with $7.5 million at  the beginning of  the fiscal year.
          The ratio  of total  debt to  shareholders'  equity also  declined
          slightly over this period to 3.0 percent at January 31, 1997.  The
          Company believes that its low debt-to-equity ratio is an important
          indicator of its ability to borrow funds should needs arise.


          RESULTS OF OPERATIONS

          For  the third  quarter and  nine months  ended January  31, 1997,
          combined product sales and service revenue increased $7.7  million
          and $10.1 million,  respectively, from  the comparable periods  of
          the  prior year.   These  represented increases  of 9  percent and
          4 percent, respectively.   Both product sales  and service revenue
          were higher in each period this year.

          The  year-to-year growth  in product  sales in  the third  quarter
          resulted  primarily  from  increased  shipments of  the  Company's
          computerized  signmaking equipment  and aftermarket  supplies, and
          computer-to-plate imaging systems for the printing industry.  On a
          nine-month basis,  the Company  also recorded  higher year-to-year
          sales  of  its  optical  lens  manufacturing  equipment.     These
          increases were partially offset by a decline in sales of automated
          fabric cutting and  spreading systems for the apparel  and related
          industries. 

          Gross  profit margins  on product  sales were  46 percent  in this
          year's third quarter, substantially unchanged from 46.1 percent in
          the same period  last year.   On a nine-month basis,  gross profit
          margins on product sales were 45.2 percent this year compared with
          46.3  percent  last  year.    Year-to-date  product  margins  were
          pressured by lower sales  volume in fabric cutting systems  in the
          first  six months  of  the current  fiscal  year.   Service  gross
          margins  were slightly lower in  the third quarter  but higher for
          the first nine months of the current year.
           
          Selling, general, and administrative expenses were higher in  this
          year's third  quarter and  first  nine months,  reflecting  higher
          marketing and other expenses associated  with the growth in sales.
          As  a percentage of revenue, SG&A expenses increased to 31 percent
          in  this year's third quarter from 30.4 percent in the same period
          last year.   For  the first nine  months, SG&A expenses  were 32.1
          percent  of  revenue this  year compared  with  31 percent  in the
          corresponding  period  last  year.     These  increases  reflected
          advertising  campaigns, exhibition costs,  and post-sales expenses
          associated   with   the  promotion   of   certain   new  products,
          particularly  the  Company's  line  of  computer-to-plate  imaging
          systems for the printing industry. 

          The Company's  investment in research  and the development  of new
          products was higher  in the current  year.  For the  third quarter
          and   first  nine  months  of   the  current  year,  R&D  expenses
          represented 8.1 percent and 7.9 percent of revenue,  respectively,
          compared with 7.8 percent and 7.1 percent in the same periods last
          year.    The  higher level  of  expenditure  in  the current  year
          reflected, in part, the  Company's efforts to broaden the  line of
          computer-to-plate imaging systems and related products.  
                                          
                                        10
<PAGE>13
        
          Interest expense  for this  year's third  quarter  and first  nine
          months ended  January 31, 1997 was slightly lower than in the same
          periods last year as a result of lower debt levels.   Other income
          in this year's first nine months  was higher than last year due to
          a  second quarter gain  of $1 million  ($.04 per  share) from life
          insurance benefits the Company  received upon the death of  Mr. H.
          Joseph  Gerber,  the  Company's  former  Chairman  and  President.
          Excluding  this item, other income  was lower in  the current year
          periods reflecting lower interest income from a smaller investment
          portfolio of tax-exempt municipal bonds.  

          The  income tax provision rate  for the quarter  ended January 31,
          1997  was approximately  30 percent,  but was  lower for  the nine
          months  ended January 31, 1997 as a  result of the tax-exempt life
          insurance benefits  noted  above.   Without  this  item,  the  tax
          provision rate  would have been  approximately 30 percent  in this
          year's first nine months.  The comparable tax rates for  the third
          quarter and first nine months of last year were 28  percent and 29
          percent, respectively.   The Company's effective  income tax  rate
          continued to be lower  than the 35 percent statutory  U.S. Federal
          tax rate principally  because of tax-exempt  interest income,  the
          tax  benefits of the Company's foreign  sales corporation, and, in
          the current year, the tax-exempt life insurance benefits.

          As  a result of the  aforementioned, net earnings  for this year's
          third quarter ended January 31, 1997 were $4.1 million or $.18 per
          share  compared with  $5.2 million  or $.22  in last  year's third
          quarter.  For the nine months ended January 31, 1997  net earnings
          totalled   $10.9  million   or  $.47   per  share   compared  with
          $15.2 million or $.64 per share in the same period last year.


          FORWARD-LOOKING STATEMENTS

          This report includes forward-looking statements that describe  the
          Company's business prospects.  Readers should keep in mind factors
          that  could  have an  adverse impact  on  those prospects.   These
          include  political,  economic,   or  other  conditions,  such   as
          recessionary   or  expansive  trends,  inflation  rates,  currency
          exchange  rates,  taxes and  regulations  and  laws affecting  the
          business, as well  as product competition, pricing, the  degree of
          acceptance of new  products to the marketplace, and the difficulty
          of forecasting sales at various times in various markets.
         

                                          11
<PAGE>14

                              PART II - OTHER INFORMATION



          Item 1.  Legal Proceedings

          In  December, 1996  the Court  of Appeals  for the  United Kingdom
          reduced the award  to the  Company from Lectra  Systemes, S.A.  of
          France and its U.K.  subsidiary (Lectra) in a  patent infringement
          suit.   The  earlier award  to the  Company by  the High  Court of
          Justice,  Chancery  Division,  had  been  for  approximately  $5.9
          million, which  was paid to the Company  but was not recognized as
          income pending the outcome of the appeals process.  As a result of
          the Court of  Appeals decision,  the Company was  required to  pay
          back  to  Lectra   approximately  $3.1  million,   which  included
          interest.  The Company is pursuing further appeal of the issues in
          this litigation and has deferred any income recognition until such
          time as the uncertainty is resolved.

          Item 5.  Other Information

          On February 17, 1997, Michael J. Cheshire was appointed President,
          Chief  Operating Officer, and  a Director  of the  Company pending
          shareholder approval of an  expansion of the Board.   Mr. Cheshire
          has  responsibility for managing  the Company's  operations, which
          are conducted  primarily through  four wholly  owned subsidiaries.
          Mr.  Cheshire  was  formerly  the  President  of  General   Signal
          Corporation's Electrical  Group.  George M.  Gentile, who formerly
          held the  titles of  President and Chief  Operating Officer,  will
          continue to  serve as Chairman of the Board of Directors and Chief
          Executive Officer of the Company.

          Item 6.  Exhibits and Reports on Form 8-K

          (a)  Exhibits

               (10)    Employment  Agreement  dated as  of January  29, 1997
                       between the Company and Michael J. Cheshire.

               (11)    Statement   regarding   computation   of  per   share
                       earnings.

               (15)    Letter   regarding   unaudited    interim   financial
                       information.

          (b)  Reports on Form 8-K

               No  Form  8-K was  filed during  the  quarter for  which this
               report is filed.


                                          12

<PAGE>15

                                      SIGNATURE



        Pursuant to the requirements  of the Securities Exchange Act  of 1934,
        the Registrant  has duly caused this report to be signed on its behalf
        by the undersigned thereunto duly authorized.



                                                  GERBER SCIENTIFIC, INC. 
                                              -------------------------------
                                                       (Registrant)     
          


        Dated:  February 25, 1997         By: /s/ Gary K. Bennett          
               -------------------            -------------------------------
                                              Senior Vice President, Finance
                                              and Principal Financial Officer<PAGE>



                                          13
<PAGE>16

                                    EXHIBIT INDEX


          Exhibit Index
             Number                             Exhibit                Page
          -------------                         -------                 ----

              10                  Employment Agreement dated as
                                  of January 29, 1997 between the
                                  Company and Michael J. Cheshire*       18  
                            


              11                  Statement Regarding Computation 
                                  of Per Share Earnings*                 28  
                          

              15                  Letter Regarding Unaudited Interim
                                  Financial Information*                 29







          *Filed herewith

<PAGE>17

                                                                 EXHIBIT 10



                                 EMPLOYMENT AGREEMENT

                    EMPLOYMENT  AGREEMENT  (the  "Agreement") dated  as  of
          January 29, 1997 between GERBER  SCIENTIFIC, INC., a  Connecticut
          corporation   (the  "Company")  and   MICHAEL  J.  CHESHIRE  (the
          "Executive") (the  Company and the Executive  may collectively be
          referred to as the "Parties"); 

                    WHEREAS,  the Board  of  Directors of  the Company  has
          determined  that it  is  to the  advantage  and interest  of  the
          Company to employ  the Executive, upon  the terms and  conditions
          hereinafter provided; and

                    WHEREAS,  the  Executive desires  to  accept employment
          with  the  Company, upon  the  terms  and conditions  hereinafter
          provided; 

                    NOW, THEREFORE,  in consideration  of the promises  and
          the mutual  covenants  contained herein,  the Parties,  intending
          legally to be bound, agree as follows:  

                                      ARTICLE I.

                                     Definitions

                1.1      As   used  in   this  Employment   Agreement,  the
          following terms shall have the meanings set forth below:  

                    "Affiliate" shall mean a corporation which, directly or
          indirectly, controls, is controlled by or is under common control
          with the  Company, or which  is a  successor in  interest to  the
          Company,  and  for  purposes  hereof, "control"  shall  mean  the
          ownership of  20% or more of the voting shares of the corporation
          in question.  

                    "Change of  Control" shall mean (a)  the acquisition by
          any person (including a group within the meaning of Section 13(d)
          (3)  or 14 (d) (2) of the  Exchange Act but excluding the Company
          or  any of its subsidiaries) of  beneficial ownership (within the
          meaning  of Rule 13d-3 promulgated under the Exchange Act) of 30%
          or  more of  the  combined voting  power  of the  Company's  then
          outstanding voting  securities; (b) the first  purchase of Common
          Stock  of  the Company  pursuant to  a  tender offer  or exchange
          offer,  other than  an  offer  by  the  Company  or  any  of  its
          subsidiaries; or (c) approval by shareholders of the Company of a
          merger, consolidation, liquidation or dissolution of the Company,
          or of the sale of all or  substantially all of the assets of  the
          Company.  

                    "Effective Date" shall mean February 17, 1997.  

                    "Former  Employer"  shall  mean  the  employer  of  the
          Executive immediately prior to the execution and delivery of this
          Agreement.  
<PAGE>18

                    "Performance Unit" shall have  the meaning set forth in
          the Gerber  Scientific, Inc. 1992 Employee Stock  Plan as Amended
          and Restated as of April 28, 1995.  

                    "Person"    shall    mean    any    individual,    sole
          proprietorship, partnership, joint venture, trust, unincorporated
          organization,   association,  corporation,   institution,  public
          benefit corporation, entity or government.  

                    "Subsidiary" shall  mean a corporation, 50%  or more of
          the  outstanding voting  shares of which  is owned  or controller
          directly or indirectly by the Company.  

                    Wherever from  the context it appears appropriate, each
          word or phrase stated  in either the singular or the plural shall
          include the singular and  the plural, and each pronoun  stated in
          the  masculine,  feminine  or  neuter gender  shall  include  the
          masculine, feminine and neuter.  

                                     ARTICLE II.

                          Employment and Duties of Executive

                2.1      Employment;  Titles; Duties.   The  Company hereby
          agrees to employ  the Executive and the Executive  hereby accepts
          his  appointment as President and  Chief Operating Officer of the
          Company,  commencing on  the Effective  Date.   As President  and
          Chief Operating Officer, the Executive  shall perform all of  the
          duties normally  associated with  that position in  a corporation
          generally comparable in size  and nature of the Company,  acting,
          in all instances, under  the supervision and direction of  and in
          accordance with the policies set by the Board of Directors and by
          the  Chief Executive  Officer of  the Company  (the "CEO").   The
          Company shall use its best efforts to cause the Executive to be a
          member of its Board of Directors for so long as he is employed by
          the Company  and during such  period of employment  shall include
          him in the  management slate  for election as  a director at  any
          stockholders' meeting  at which his term  would otherwise expire.
          If elected or appointed  as a director, the Executive  will serve
          in such capacity without any additional compensation.  

                2.2      Performance of Duties.  The Executive shall devote
          his  full  working time  and efforts  to  the performance  of his
          duties as an executive  of the Company and to the  performance of
          such other  duties  as  are  assigned to  him  by  the  Board  of
          Directors of the Company or the CEO.  

                                     ARTICLE III.

                              Compensation and Benefits

                    The Company shall pay the Executive as compensation for
          all  of  the  services  to  be  rendered  by  him  hereunder  the
          compensation and  other benefits  as provided for  and determined
          pursuant to this Article III.  
<PAGE>19

                3.1      Base Compensation.    The Company  shall  pay  the
          Executive  a  base  salary  of  $350,000  per  annum  (the  "Base
          Compensation"), payable  in accordance with  the regular  payroll
          practices of the Company for  executives, less such deductions or
          amounts  as are  required to  be deducted  or withheld  from such
          compensation  by applicable  laws  or regulations  and less  such
          other deductions or  amounts, if  any, as are  authorized by  the
          Executive.    The Base  Compensation  of the  Executive  shall be
          subject to review  on the  same schedule and  following the  same
          process as employed, from time to time, for principal officers of
          the Company.  

                3.2      Benefits.  

                    (a) Standard Existing Company Benefits.   The Executive
          shall be entitled to participate in all of the benefit plans made
          generally  available  to   the  Company's  employees   (including
          medical,  dental,  life  and disability  insurance,  and  pension
          benefits) as  described  in the  brochure attached  as Exhibit  A
          hereto; provided, however, nothing  contained in this Section 3.2
          shall  be deemed  to  limit in  any way  the  Company's right  to
          modify,  amend  or  terminate  any   plan  now  or  hereafter  in
          existence.  Notwithstanding the foregoing or  any language to the
          contrary,  Company  benefits  as  described in  Exhibit  A  shall
          commence on the first day of Executive's employment.  

                    (b) Additional  Benefits.  In addition  to the benefits
          listed  in  Section  3.2(a),  the Company  shall  provide  to the
          Executive:  

                        (i) Four  weeks vacation in each  calendar year (It
          is understood that the Company's then existing policy on vacation
          not taken in any year shall apply to any unused vacation.); 

                        (ii) Use of a Company car similar in style and cost
          as  that  afforded  to   the  Company's  other  senior  executive
          officers; 

                        (iii)  Financial  counseling   services  of  up  to
          $10,000 per year; and

                        (iv) Participation  in the  Company's  Supplemental
          Pension Benefit Plan ("SERP").  

                3.3     Sign-on Awards and Bonus Reimbursement. 

                    (a)  The Company  shall  pay the  Executive a  one-time
          sign-on  award  of  $400,000  in  cash  in  accordance  with  the
          following schedule:  

                        (i)  $200,000  one  year  from the  Effective  Date
          (except that $100,000 of the foregoing amount shall be payable on
          the Effective Date  in the event that the Company is not required
          to  make  the Bonus  Reimbursement  specified  in Section  3.3(b)
          below; and

                        (ii) $200,000 two years from the Effective Date.  
<PAGE>20
          Any award  required to be  paid by the  Company to  the Executive
          under this Section 3.3  is hereinafter referred to as  a "Sign-on
          Award."  

                    (b) In the  event the Executive  forfeits and does  not
          receive the cash bonus  he would normally be entitled  to receive
          from his Former Employer  for his performance in 1996  because of
          his acceptance of employment with the Company, the Company shall,
          promptly  after the  Effective Date,  reimburse the  Executive an
          additional amount ("Bonus Reimbursement")  equal to the amount of
          the  cash bonus the Executive would have received from his Former
          Employer.  The Bonus  Reimbursement payable by the Company  under
          this  Section shall  not exceed  $185,000.   The Executive  shall
          furnish  the  Company such  documentation  as  may be  reasonably
          requested  by the Company to  support his request  for payment of
          any amount pursuant to this Section 3.3(b).  

                3.4     Bonuses.  

                    (a)  Bonus for Fiscal Year  Ending April 30,  1998.  In
          addition  to any  Sign-on Award  provided by  the Company  to the
          Executive pursuant to  Section 3.3 above, the  Executive shall be
          eligible  to receive a bonus for the Company's fiscal year ending
          April 30,  1998 ("1998  Fiscal Year")  of up to  a maximum  of 75
          percent of his Base Compensation, which bonus shall be calculated
          and determined  on the same basis  and terms as are  set forth in
          the  Company's annual  bonus  plan for  executives  for the  1998
          Fiscal  Year   ("1998  Bonus   Plan");  provided,  however,   the
          Executive's  bonus for  the 1998  Fiscal Year  shall not,  in any
          event, be less than $175,000.  The Executive's bonus for the 1998
          Fiscal Year shall be paid  to the Executive in cash on  or before
          July 15, 1998.  

                    (b)  Bonuses for  Fiscal Years  Subsequent to  the 1998
          Fiscal Year.  The  Executive shall be entitled to  participate in
          the  bonus  plans  adopted  by  the  Management  Development  and
          Compensation Committee  of the  Company's Board of  Directors and
          approved  by the  Company's Board of  Directors for  fiscal years
          ending after the  1998 Fiscal Year in the same  manner and on the
          same terms as other executives of the Company.  


                3.5     Options and Performance Units.  

                    (a)  Pursuant  to  the  Gerber  Scientific,  Inc.  1992
          Employee  Stock Plan,  as Amended  and Restated  as of  April 28,
          1995, (the "Performance Plan") attached hereto as Exhibit B,  the
          Executive shall  be granted (i) options to purchase 30,000 shares
          of the Company's Common Stock and (ii) 7,500 Performance Units.  

                    Such options will vest and become exercisable after six
          years in accordance with  the terms of the Performance  Plan, but
          the  terms of grant will provide that vesting will be accelerated
          as  provided  in  the  table  below  in  the  event  that  annual
          compounded growth  in the  Company's earnings per  share ("EPS"),
          measured from the EPS ($.076) for the Company's fiscal year ended
          April 30, 1995 ("1995 Fiscal Year") to the end of the 1998 Fiscal
          Year  (April 30,  1998) or to  the end of  each successive fiscal
<PAGE>21
          year  thereafter through April  30, 2000,  equals or  exceeds the
          Annual Compounded EPS growth rates set forth below:  

                    Annual Compound     Percent of Options as to which
                       EPS Growth            Vesting is Accelerated      

                         18%                        100%
                         17%                         80%
                         16%                         60%
                         15%                         40%
                         14%                         20%

                    To the  extent that options  vest early because  of the
          achievement  of the  foregoing EPS  growth performance  criteria,
          Performance Units shall  also vest and  be payable in  accordance
          with  the terms  of the Performance  Plan, to  the extent  of one
          Performance  Unit  for  each  four options  vesting.    Under the
          Performance  Plan,  each employee  selected  to  receive a  grant
          ("Participant") is  required to  execute an Agreement  which will
          set forth the  terms of  the grant ("Grant  Agreement") and  each
          such  Grant Agreement is required to provide that payment under a
          Performance Unit, if earned,  is subject to the condition  that a
          participant has previously exercised or  simultaneously exercises
          a related option (i.e., an option granted to a Participant at the
          same time as the Performance Units are granted and which vests at
          the  same time as, or earlier than, such Performance Unit vests).
          The  Performance  Plan also  provides  that,  subject to  certain
          exceptions set forth  in such  Plan, a Performance  Unit will  be
          paid  only while a Participant remains employed by the Company or
          one  of  its Subsidiaries.    All options  and  Performance Units
          granted to the Executive  will be subject to and governed  by the
          terms of the Performance Plan.  

                    (b)  Additional Options.   In  May 1997,  the Executive
          shall  be  granted  options  to purchase  120,000  shares  of the
          Company's  Common Stock  under the Performance  Plan on  the same
          terms as options will be granted at such time, to other executive
          officers of the Company under such Plan.  
<PAGE>22

                                     ARTICLE IV.

                          Termination and Severance Payments

                4.1      Termination  Without  Cause.    Either  party  may
          terminate this  Agreement at any  time for any  reason; provided,
          however:  

                    (a)  if  Executive  terminates his  employment  by  the
          Company, for whatever reason, Executive shall be  entitled to his
          Base Compensation up to the date of his termination and, further,
          shall  be entitled to retain  all amounts previously  paid by the
          Company  prior  to  such  termination   date  including,  without
          limitation, Sign-on Bonuses and  Bonus Reimbursement.   Executive
          shall not be entitled to any amounts payable by the Company under
          this Agreement or otherwise after the termination date.  

                    (b)   if  the   Company   terminates  the   Executive's
          employment  under this Agreement  for any  reason other  than for
          cause as described in Section 4.2 herein, the Executive shall  be
          entitled to receive:  

                         (i)  his Base  Compensation  through  the date  of
          termination and for an  additional eighteen (18) months following
          the date of termination;  

                         (ii) any unpaid portion of any bonus earned by the
          Executive for any then completed fiscal year of the Company, plus
          the pro-rata  portion of  the  Executive's target  bonus for  any
          portion  of  a  fiscal year  completed  prior  to  termination of
          employment, plus the pro-rata  portion of his target bonus  for a
          period of eighteen (18) months from the date of such termination.
          For purposes of this Article IV, the Executive's target bonus for
          any  particular year shall equal  fifty (50) percent  of his Base
          Compensation   for  such   year  or   if  the   Executive's  Base
          Compensation has not  then been  set for a  particular year,  the
          target bonus for  such year  shall be fifty  (50) percent of  his
          then current Base Compensation; 

                    (c) the balance of any unpaid Sign-on Award; and

                    (d)  medical benefits  for  a period  of eighteen  (18)
          months following the date of termination.  

                4.2      Termination for  Cause.  If  the Executive engages
          in  (a) fraud,  (b) embezzlement, (c)  any other  crime involving
          moral turpitude, (d) gross  or willful neglect of duty,  (e) such
          conduct  as results or as is likely  to result in material damage
          to the  reputation of the Company  or any of the  Subsidiaries or
          Affiliates of the  Company, or (f) if  the Executive declines  to
          follow any significant instruction or policy (which is both legal
          and reasonable)  of the CEO or  of the Board of  Directors of the
          Company which  instruction or policy is  formally communicated to
          the Executive,  or if  the Executive  adheres to  such persistent
          refusal  or neglect to  follow such  instructions or  policy, the
          Company  may at  any  time thereafter  terminate the  Executive's
          employment   hereunder  by  written   notice  to  him,  effective
          immediately and the date  of the notice shall be  the Termination
<PAGE>23

          Date  hereunder.   Any  such termination  shall  be deemed  to be
          termination  for cause, for purposes  of this Agreement.   If the
          Executive's employment  is terminated for  cause hereunder,  then
          the Executive  shall be  entitled to  receive only  the following
          payments:   (a) any portion  of his Base  Compensation accrued to
          the date of such termination and not theretofore paid to him; and
          (b)  reimbursement  for any  expenses  properly  incurred by  the
          Executive, and supported by appropriate vouchers,  which expenses
          have  been incurred  prior to  the date  of such  termination and
          which  have not theretofore been reimbursed.  Except as set forth
          in  the immediately  preceding sentence,  all of  the Executive's
          rights  to   compensation  and   benefits   hereunder  shall   be
          terminated, in the event of termination for cause, as of the date
          the Executive is terminated.  

                4.3      Termination Following  Change of Control.   If the
          Executive's employment under this  Agreement is terminated by the
          Company or  his position  as described  in Section 2.1  herein is
          reduced by  the  Company, at  any  time within  twenty-four  (24)
          months following a change in control, Executive shall be entitled
          to receive:  

                    (a)  his   Base  Compensation   through  the   date  of
          Termination  and  for  an  additional  twenty-four  (24)   months
          following the date of termination; 

                    (b)  any unpaid  portion  of any  bonus  earned by  the
          Executive for any then completed fiscal year of the Company, plus
          the pro-rata  portion of  the  Executive's target  bonus for  any
          portion  of  a  fiscal year  completed  prior  to  termination of
          employment, plus the pro-rata  portion of his target bonus  for a
          period  of  twenty-four  (24)  months  from   the  date  of  such
          termination; 

                    (c) the balance of any unpaid Sign-on Award; and

                    (d) medical  benefits for a period  of twenty-four (24)
          months following the date of termination.  

                4.4      Death  or Disability.   If  the Executive  dies or
          becomes partially or totally disabled during his employment under
          this  Agreement  and  is  thus  unable  to  fulfill his  assigned
          responsibilities,  he shall be entitled to receive the balance of
          any  unpaid Sign-on Award and  such other death and/or disability
          benefits  as  employees  of  the Company  are  then  entitled  to
          receive.   Except  as herein  provided,  all of  the  Executive's
          rights to  compensation and  benefits  hereunder shall  terminate
          upon such death or disability.  

                4.5      Other  Termination of Employment by the Executive.
          If the  Executive voluntarily terminates his  employment, then he
          shall be entitled  to receive  only those payments  set forth  in
          Section 4.2 hereof.  
<PAGE>24

                                      ARTICLE V.

                   Representations and Warranties by the Executive

                5.1      To   induce  the   Company  to  enter   into  this
          Agreement, the Executive hereby  represents and warrants that, as
          of  the  Effective Date,  he  is not  a  party to  any agreement,
          contract or  understanding, which  would in  any way restrict  or
          prohibit  him   from  undertaking   or  performing  any   of  his
          obligations  under   this  Agreement,   and  that  no   facts  or
          circumstances exist which would prohibit him from doing so.  

                                     ARTICLE VI.

                  Confidential Information and Proprietary Interests

                6.1      Confidentiality  and  Inventions  Agreement.   The
          Executive  agrees  to  execute   and  deliver,  immediately  upon
          execution  and   delivery  of   this   Agreement,  that   certain
          Confidentiality  and Inventions  Agreement  in the  same form  as
          signed by  other employees  of the  Company, a  copy of  which is
          attached hereto as Exhibit C.  


                                     ARTICLE VII.

                                       Notices

                7.1      Notice.   Notices  and  all  other  communications
          provided  for   hereunder  shall  be  in  writing  and  shall  be
          sufficient  in all  respects if  delivered or  sent by  certified
          mail, return receipt  requested, addressed,  in the  case of  the
          Company, to  the Company at  83 Gerber Road West,  South Windsor,
          Connecticut  06074,   Attention:    Chairman  of   the  Board  of
          Directors,  with a copy to the Secretary,  or, in the case of the
          Executive,  to  the Executive  at  164  Main Street,  Farmington,
          Connecticut 06032 or,  in either  case to such  other address  as
          either  party may  have  furnished to  the  other in  writing  in
          accordance  herewith; except  that  notice of  change of  address
          shall be effective only upon receipt.  


                                    ARTICLE VIII.

                              Assignment and Successors

                8.1      Neither this  Agreement nor  any of his  rights or
          duties hereunder may be  assigned or delegated by the  Executive.
          This Agreement  shall be binding  upon and, except  as aforesaid,
          shall  inure to the benefit  of the Parties  and their respective
          successors and permitted assigns.  
<PAGE>25

                                     ARTICLE IX.

                             Entire Agreement and Waiver

                9.1      Integration.    This  Agreement and  the  Exhibits
          hereto contain  the entire  agreement of the  Parties hereto  and
          supersede all  previous  agreements between  the Parties  hereto,
          written or oral, express or  implied, covering the subject matter
          hereof.  No representations, inducements, promises or agreements,
          oral or otherwise, not  embodied herein shall be of any  force or
          effect.   This  Agreement  may not  be  amended, supplemented  or
          rescinded except by instrument in  writing signed by both Parties
          hereto.  

                9.2      No  Waiver.  No  waiver or modification  of any of
          the provisions of this Agreement shall be valid unless in writing
          and signed by  or on behalf of the Party  granting such waiver or
          modification.   No waiver by  any Party of  any breach or default
          hereunder  shall be  deemed a  waiver of  any repetition  of such
          breach or default or shall be deemed a waiver of any other breach
          or default, nor shall it in any way affect any of the other terms
          or conditions  of this  Agreement or the  enforceability thereof.
          No  failure of  the  Company  to  exercise  any  power  given  it
          hereunder  or to insist  upon strict compliance  by the Executive
          with  any  obligation hereunder,  and  no custom  or  practice at
          variance  with the terms hereof, shall constitute a waiver of the
          right of the Company  to demand strict compliance with  the terms
          hereof.  


                                      ARTICLE X.

                                    Governing Law

                10.1     This Agreement shall be governed by and construed,
          and the rights and obligations of the Parties hereto enforced, in
          accordance with the laws of the State of Connecticut.  


                                     ARTICLE XI.

                                       Headings

                11.1     The Article and  Section headings contained herein
          are for reference  purposes only and shall not  in any way affect
          the meaning or interpretation of this Agreement.  
<PAGE>26

                    IN WITNESS  WHEREOF,  the Parties  have  executed  this
          Agreement  as of  the date  first written  above, which  shall be
          deemed to be the Effective Date.  


                                             GERBER SCIENTIFIC, INC. 



                                             By:  _____________________
                                                George M. Gentile



                                             MICHAEL J. CHESHIRE


                                             ________________________
<PAGE>27


                                                               EXHIBIT NO. 11



                              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

                                 COMPUTATION OF PER SHARE EARNINGS



<TABLE>
<CAPTION> 
                                            Three Months                 Nine Months
                                                Ended                       Ended
                                              January 31                   January 31           
                                     ---------------------------   ---------------------------
                                         1997           1996           1997           1996    
                                     ------------   ------------   ------------   ------------
   <S>                               <C>            <C>            <C.            <C>              
   Net earnings                      $  4,144,000   $  5,151,000   $ 10,882,000   $ 15,177,000 
                                     ============   ============   ============   ============


   Weighted average shares of
     common stock outstanding
     during the period                 23,260,861     23,294,950     23,234,334     23,559,975


   Common stock equivalents:

     Common stock attributable
     to stock options (treasury
     stock method)                         95,925        221,007        118,003        247,867
                                     ------------   ------------   ------------   ------------

   Average common shares
     outstanding                       23,356,786     23,515,957     23,352,337     23,807,842
                                     ============   ============   ============   ============

   Net earnings per common share     $        .18   $        .22   $        .47   $        .64
                                     ============   ============   ============   ============


</TABLE>

<PAGE>28


                                                             EXHIBIT NO. 15



          To the Board of Directors and Shareholders of
          Gerber Scientific, Inc.



                       Re:  Registration Statements on Form S-8
                            File No. 2-93695 and No. 33-58668

                            Registration Statement on Form S-3,
                            File No. 33-58670



          With  respect   to  the   subject  Registration  Statements,   we
          acknowledge  our awareness of the use therein of our report dated
          February 19,  1997  related to  our review  of interim  financial
          information.

          Pursuant to  Rule 436(c) under  the Securities Act,  such reports
          are not considered a part of a Registration statement prepared or
          certified by an accountant  or a report prepared or  certified by
          an accountant within the meaning of Sections 7 and 11 of the Act.


                                        Very truly yours,



     
                                       /s/ KPMG PEAT MARWICK LLP

          Hartford, Connecticut
          February 19, 1997